STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 97 filers reported holding STOKE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $128,629 | -62.7% | 32,647 | +0.5% | 0.00% | -66.7% |
| Q2 2023 | $345,284 | +42.5% | 32,482 | +11.7% | 0.00% | +50.0% |
| Q1 2023 | $242,278 | -1.9% | 29,085 | +8.7% | 0.00% | 0.0% |
| Q4 2022 | $246,893 | -10.5% | 26,749 | +24.3% | 0.00% | -33.3% |
| Q3 2022 | $276,000 | -10.1% | 21,515 | -7.4% | 0.00% | 0.0% |
| Q2 2022 | $307,000 | -62.0% | 23,245 | -39.5% | 0.00% | -66.7% |
| Q1 2022 | $808,000 | -20.9% | 38,393 | -9.8% | 0.01% | -18.2% |
| Q4 2021 | $1,021,000 | -10.9% | 42,571 | -5.5% | 0.01% | 0.0% |
| Q3 2021 | $1,146,000 | -29.6% | 45,034 | -6.9% | 0.01% | -21.4% |
| Q2 2021 | $1,627,000 | – | 48,351 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 296,822 | $9,991,000 | 2.07% |
| RTW INVESTMENTS, LP | 3,644,248 | $122,665,000 | 1.85% |
| Cormorant Asset Management, LP | 1,278,276 | $43,027,000 | 1.46% |
| Redmile Group, LLC | 2,458,558 | $82,755,000 | 1.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 233,135 | $7,847,000 | 0.53% |
| Birchview Capital, LP | 15,000 | $505,000 | 0.30% |
| Perceptive Advisors | 1,343,956 | $45,238,000 | 0.29% |
| GILDER GAGNON HOWE & CO LLC | 1,245,956 | $41,939,000 | 0.21% |
| Artal Group S.A. | 250,000 | $8,415,000 | 0.17% |
| Casdin Capital, LLC | 120,000 | $4,039,000 | 0.10% |